Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.020
-0.100 (-3.21%)
Feb 12, 2026, 4:00 PM EST - Market closed
MRVI Market Cap
MRVI has a market cap or net worth of $772.23 million as of February 13, 2026. Its market cap has increased by 8.24% in one year.
Market Cap
772.23M
Enterprise Value
896.60M
1-Year Change
8.24%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $772.23M, a decrease of -68.21%. That is a compound annual growth rate of -19.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 437.97M | -7.08% |
| Dec 31, 2025 | 471.32M | -39.03% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 800.59M |
| Janux Therapeutics | 789.74M |
| Annexon | 772.85M |
| Arbutus Biopharma | 771.22M |
| Bicara Therapeutics | 770.23M |
| KalVista Pharmaceuticals | 763.50M |
| Arvinas | 760.09M |
| Bright Minds Biosciences | 755.25M |